Kelleigh Strickland
Nurse Practitioner · Bountiful, UTNPI 1649338856
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,815 of the $4,726 with a category attached, or 80.7%. It is spread thinly across 32 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,794 and has fallen 97.9% since, to $37 in 2024. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $23.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- AstraZeneca$742
- Novo Nordisk$513
- Lilly USA, LLC$347
- Corcept Therapeutics$314
- AbbVie$267
- plus $1K from 26 others
What the payments were for
- Consulting fees$80017%
- Travel & lodging$1122%
- Food & beverage$3,81581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 12 | $1,079 |
| AstraZeneca | 24 | $742 |
| Novo Nordisk | 21 | $513 |
| Lilly USA, LLC | 29 | $347 |
| Corcept Therapeutics | 11 | $314 |
| AbbVie | 16 | $267 |
| GSK | 10 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $140 |
| E.r. Squibb & Sons, L.L.C. | 7 | $124 |
| Idorsia Pharmaceuticals US Inc | 6 | $106 |
| Bayer | 6 | $105 |
| Amgen | 6 | $93 |
| Sanofi-aventis U.S. LLC | 6 | $90 |
| Boehringer Ingelheim | 6 | $84 |
| Pfizer | 4 | $74 |
| Astellas Pharma US Inc | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $27 |
| Genentech USA, Inc. | 2 | $24 |
| Boston Scientific | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Bardy Diagnostics, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Merck | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$912
- FARXIGA$120
- BREZTRI$118
- Korlym$117
How this compares
$4,726 in reported general payments places this provider in the 95th percentile of 979 nurse practitioner providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 13 | $15,919 |
| MounjaroTirzepatide | 12 | $14,471 |
| Amiodarone Hcl | 16 | $595 |
| Rosuvastatin Calcium | 36 | $389 |
| Valsartan | 20 | $282 |
| Amlodipine Besylate | 59 | $229 |
| Gabapentin | 11 | $215 |
| Hydralazine Hcl | 12 | $170 |
| Fluticasone Propionate | 15 | $162 |
| Levothyroxine Sodium | 26 | $153 |
| Atorvastatin Calcium | 25 | $152 |
| Omeprazole | 20 | $117 |
| Lisinopril | 29 | $97 |
| Losartan Potassium | 14 | $87 |
| Simvastatin | 15 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $347 | $30,39125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 979 nurse practitioner providers in Utah.
Other nurse practitioner in Bountiful
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
- Stacie EganOgden$170K
- Traci AndreasonLehi$161K
- Geoffrey OsmondDraper$62K
- Trenton GraySouth Salt Lake$40K
- Kelsey FurrWest Jordan$21K
- Merin KinikiniSalt Lake City$19K
- Lynn LarsenOgden$16K
- Phillip BowmanSalt Lake City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.